IOVANCE BIOTHERAPEUTICS, INC. Quarterly Unrecognized Tax Benefits in USD from Q4 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Iovance Biotherapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2014 to Q4 2023.
  • Iovance Biotherapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $26.1M, a 20.6% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $26.1M +$4.46M +20.6% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $21.6M +$3.47M +19.1% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $18.2M +$3.74M +25.9% Dec 31, 2021 10-K 2024-02-28
Q4 2020 $14.4M +$4.39M +43.8% Dec 31, 2020 10-K 2024-02-28
Q4 2019 $10M +$3.69M +58.2% Dec 31, 2019 10-K 2023-02-28
Q4 2018 $6.34M +$2.23M +54.3% Dec 31, 2018 10-K 2022-02-24
Q4 2017 $4.11M +$4.11M Dec 31, 2017 10-K 2021-02-25
Q4 2016 $0 $0 Dec 31, 2016 10-K 2020-02-25
Q4 2015 $0 $0 Dec 31, 2015 10-K 2019-02-28
Q4 2014 $0 Dec 31, 2014 10-K 2018-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.